Literature DB >> 11509121

Enhanced formation of azoxymethane-induced colorectal adenocarcinoma in gammadelta T lymphocyte-deficient mice.

S Matsuda1, S Kudoh, S Katayama.   

Abstract

T cell receptor (TCR) gammadelta-positive T lymphocytes, which are localized mostly within the intraepithelial space of intestinal epithelium, have been suggested to play a role in maintaining the normal configuration of intestinal epithelium. However, the role of TCRgammadelta-positive T lymphocytes in the formation and progression of colorectal adenocarcinoma that originates from colorectal epithelial cells remains to be elucidated. In this study, TCRalphabeta and TCRgammadelta-positive T lymphocyte-deficient mice (homozygous TCRa and TCRd-gene knockout mice) and the background wild-type mice were administered azoxymethane, and the formation of macroscopic tumors and microscopic aberrant crypt foci in colorectal mucosa were compared among the three types of mice. Well-differentiated adenocarcinoma appeared 5 months after 5 administrations of azoxymethane (10 mg/kg weight) only in a few TCRd -gene knockout mice and the frequency of the carcinoma-bearing mice was increased at 7 and 9 months after the administration. Aberrant crypt foci were also detected in the colorectal mucosa of TCRd -gene knockout mice to a greater extent than in colorectal mucosa of TCRa-gene knockout mice 1 month after the azoxymethane administration. These results suggest that TCRgammadelta-positive T lymphocytes, which are present mainly in the intraepithelial space, play a role in suppression of the formation and progression of colorectal adenocarcinoma in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509121      PMCID: PMC5926836          DOI: 10.1111/j.1349-7006.2001.tb01176.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  22 in total

1.  Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA.

Authors:  M Maeurer; L Zitvogel; E Elder; W J Storkus; M T Lotze
Journal:  Nat Immun       Date:  1995-04

2.  Superantigen reactivity of gamma delta T cell clones isolated from patients with multiple sclerosis and controls.

Authors:  P Stinissen; C Vandevyver; J Raus; J Zhang
Journal:  Cell Immunol       Date:  1995-12       Impact factor: 4.868

3.  Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.

Authors:  N Seo; Y Tokura; M Takigawa; K Egawa
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

4.  Enhancing effect of tumor necrosis factor (TNF)-alpha, but not IFN-gamma, on the tumor-specific cytotoxicity of gammadeltaT cells from glioblastoma patients.

Authors:  Y Suzuki; Y Fujimiya; T Ohno; R Katakura; T Yoshimoto
Journal:  Cancer Lett       Date:  1999-06-01       Impact factor: 8.679

5.  Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.

Authors:  C Lundqvist; S Melgar; M M Yeung; S Hammarström; M L Hammarström
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

6.  Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.

Authors:  R M Housley; C F Morris; W Boyle; B Ring; R Biltz; J E Tarpley; S L Aukerman; P L Devine; R H Whitehead; G F Pierce
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

Authors:  P Mombaerts; A R Clarke; M A Rudnicki; J Iacomini; S Itohara; J J Lafaille; L Wang; Y Ichikawa; R Jaenisch; M L Hooper
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

8.  Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.

Authors:  H H van Ravenswaay Claasen; P M Kluin; G J Fleuren
Journal:  Lab Invest       Date:  1992-08       Impact factor: 5.662

9.  In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.

Authors:  Y Fujimiya; Y Suzuki; R Katakura; T Miyagi; T Yamaguchi; T Yoshimoto; T Ebina
Journal:  Clin Cancer Res       Date:  1997-04       Impact factor: 12.531

10.  Different pattern of T cell receptor delta gene rearrangement in tumour-infiltrating lymphocytes and peripheral blood in patients with solid tumours.

Authors:  D Kowalczyk; W Skorupski; M Drews; J Nowak
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

View more
  7 in total

1.  Colon carcinogenesis in wild type and immune compromised mice after treatment with azoxymethane, and azoxymethane with dextran sodium sulfate.

Authors:  Ryan D Whetstone; Uwe A Wittel; Nicole M Michels; James M Gulizia; Barry Gold
Journal:  Mol Carcinog       Date:  2015-07-08       Impact factor: 4.784

2.  TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets.

Authors:  Bernardo S Reis; Patrick W Darcy; Iasha Z Khan; Christine S Moon; Adam E Kornberg; Vanessa S Schneider; Yelina Alvarez; Olawale Eleso; Caixia Zhu; Marina Schernthanner; Ainsley Lockhart; Aubrey Reed; Juliana Bortolatto; Tiago B R Castro; Angelina M Bilate; Sergei Grivennikov; Arnold S Han; Daniel Mucida
Journal:  Science       Date:  2022-07-14       Impact factor: 63.714

3.  Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation.

Authors:  Michael Girardi; Julia Lewis; Earl Glusac; Renata B Filler; Liping Geng; Adrian C Hayday; Robert E Tigelaar
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

4.  γδ T cells compose a developmentally regulated intrauterine population and protect against vaginal candidiasis.

Authors:  L Monin; D S Ushakov; H Arnesen; N Bah; A Jandke; M Muñoz-Ruiz; J Carvalho; S Joseph; B C Almeida; M J Green; E Nye; S Hatano; Y Yoshikai; M Curtis; H Carlsen; U Steinhoff; P Boysen; A Hayday
Journal:  Mucosal Immunol       Date:  2020-05-29       Impact factor: 7.313

Review 5.  Immune Effects of γδ T Cells in Colorectal Cancer: A Review.

Authors:  Rulan Ma; Dawei Yuan; Yizhan Guo; Rong Yan; Kang Li
Journal:  Front Immunol       Date:  2020-09-09       Impact factor: 7.561

6.  Chronic intestinal inflammation drives colorectal tumor formation triggered by dietary heme iron in vivo.

Authors:  Nina Seiwert; Janine Adam; Pablo Steinberg; Stefan Wirtz; Tanja Schwerdtle; Petra Adams-Quack; Nadine Hövelmeyer; Bernd Kaina; Sebastian Foersch; Jörg Fahrer
Journal:  Arch Toxicol       Date:  2021-05-12       Impact factor: 5.153

7.  γδ T Cells Control Gut Pathology in a Chronic Inflammatory Model of Colorectal Cancer.

Authors:  Suryasarathi Dasgupta; Hong Liu; Brandi Bailey; Corey Wyrick; Jessica Grieves; Chris DeBoever; Craig Murphy; Benjamin Faustin
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.